Are you above the legal age to view this content in your province/state?

Home / Industry News / The global legal marijuana market size is expected to reach USD 66.3 billion by the end of 2025

The global legal marijuana market size is expected to reach USD 66.3 billion by the end of 2025

The global legal marijuana market size is expected to reach USD 66.3 billion by the end of 2025

U.S, May, 2019 (GRAND VIEW RESEARCH)- The global legal marijuana market size is expected to reach USD 66.3 billion by the end of 2025, according to a new report by Grand View Research, Inc. It is anticipated to expand at a CAGR of 23.9% during the forecast period. Increasing legalization and use of marijuana in medical as well as recreational applications is expected to promote the growth.

Growing adoption of cannabis as a pharmaceutical product for treating severe medical conditions, such as cancer, Parkinson’s disease, Alzheimer’s disease, arthritis, and other neurological conditions is anticipated to drive demand for medical marijuana in the forthcoming years. Increasing need for pain management therapies and growing disease burden of chronic pain among elders is also expected to boost demand.

Legalization of medicinal marijuana and decriminalization in some countries has led to a significant decrease in the black market, as people are resorting to legally purchasing cannabis for medicinal as well as recreational use. Moreover, government earnings through taxation is further viewed as an opportunity for countries to earn revenues. Presence of a large customer pool and legalization of medical marijuana in U.S. and Canada is expected propel the product demand from North America.

However, legalization of medicinal cannabis in European countries, accompanied by stringent rules and regulations regarding the product sale and cultivation may limit the overall growth in Europe and in turn for the global market. Other promising markets for Cannabis are Australia, Germany, Poland, Colombia, Uruguay, and Israel. Israel is currently at the forefront of providing technology and knowledge transfer to the other world markets. As the newer markets such as the U.K. and Thailand create their legal structure for cannabis, the revenue growth is expected to witness significant growth. Moreover, countries like South Africa and New Zealand are discussing legalization for medicinal marijuana and may emerge as viable markets in the forthcoming years.

Further key findings from the report suggest:

  • U.S. legal cannabis market was valued USD 11.9 billion in 2018 and is anticipated to expand at a CAGR of 24.1% from 2019 to 2025
  • Medical cannabis held the largest market share in 2018 and is estimated to be expand at a CAGR of 12.7% by 2025 owing to increasing of marijuana for the treatment of cancer and other medicinal conditions
  • By product type, buds segment accounted for a significant market share in 2018 and is expected to expand at a CAGR of 20.6% from 2019 to 2025
  • Key players operating in the legal cannabis market include Aurora Cannabis; Canopy Growth Corporation; Maricann Group, Inc.; GW Pharmaceuticals, plc.; Aphria, Inc.; Tilray; The Cronos Group; ABcann Medicinals, Inc.; Lexaria Corp.; and Organigram Holding, Inc.

Grand View Research has segmented the global legal marijuana market on the basis of marijuana type, product type, medical application, and region:

Legal Marijuana Type Outlook (Revenue, USD Million, 2014 – 2025)

  • Medical
  • Recreational

Legal Marijuana Product Type Outlook (Revenue, USD Million, 2014 – 2025)

  • Buds
  • Oil
  • Tinctures

Legal Marijuana Medical Application Outlook (Revenue, USD Million, 2014 – 2025)

  • Chronic Pain
  • Mental Disorders
  • Cancer
  • Others

Legal Marijuana Regional Outlook (Revenue, USD Million, 2014 – 2025)

  • U.S.
  • Canada
  • Germany
  • Italy
  • Netherlands
  • Croatia
  • Poland
  • Czech Republic
  • Switzerland
  • Australia
  • Uruguay
  • Colombia
  • Mexico
  • Chile
  • Argentina
  • Israel

Disclaimer

Investment Value Finders specializes in providing opinions and information on stocks to individuals who wish to receive them. Our reports are construed for information purposes solely and are distributed free of charge to individuals who wish to receive them.


Investment Value Finders does not promote, condone or advocate licit or illicit drug use. Investment Value Finders cannot be held responsible for materials or contests posted on its website pages, or pages to which we provide links, which promote, condone or advocate licit or illicit drug use or illegal activities.


DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS WEBSITE. We are not registered as a securities broker-dealer or an investment adviser. We are neither licensed nor qualified to provide investment advice.


Investment Value Finders occasionally receives direct compensation for hosting links (or other* advertisements) to third party content that may be subject to disclaimer pursuant to Section 17(b) of the Securities Act of 1933. For those instances where the link text contains company or stock-specific mention, we provide the following list of compensation received in order to ensure full disclosure and transparency.


Investment Value Finders is intended for those 21+ years of age only!

Check Also

A U.S. Marijuana Stock Versus a Canadian Marijuana Stock

A U.S. Marijuana Stock Versus a Canadian Marijuana Stock

Which of These Pot Stocks to Watch is Showing the Most Momentum? U.S., September 10, …